NCT04928677 2026-02-17
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Chugai Pharmaceutical